RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trialDaniel Martin, Emmanouil Fokas, Jürgen Debus et al.|Clinical and Translational Radiation Oncology|2020Cited by 33
Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neckThomas Kuhnt, Juergen Dunst, Alexandra Sandner et al.|Annals of Oncology|2010Cited by 24
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neckThomas Kuhnt, Jürgen Dunst, Andreas Schreiber et al.|Strahlentherapie und Onkologie|2017Cited by 8
8501 ORAL Phase ll-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer – Early Response and Acute ToxicitiesThomas Kuhnt, Juergen Dunst, Andreas Schreiber et al.|European Journal of Cancer|2011Cited by 0